blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3650466

EP3650466 - IN VITRO PRODUCTION OF HIGH AFFINITY MONOCLONAL ANTIBODIES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.09.2022
Database last updated on 15.06.2024
FormerRequest for examination was made
Status updated on  20.11.2020
FormerThe application has been published
Status updated on  10.04.2020
Most recent event   Tooltip30.09.2022Application deemed to be withdrawnpublished on 02.11.2022  [2022/44]
Applicant(s)For all designated states
Consejo Superior De Investigaciones Científicas
C/ Serrano 117
28006 Madrid / ES
[2020/20]
Inventor(s)01 / MARTINEZ RIAÑO, Ana
CENTRO DE BIOLOGIA MOLECULAR SEVERO OCHOA (CBM)
Campus Universidad Autonoma De Madrid
C/ Nicolas Cabrera, 1
28049 Madrid / ES
02 / ALARCON SANCHEZ, Balbino
CENTRO DE BIOLOGIA MOLECULAR SEVERO OCHOA (CBM)
Campus Universidad Autonoma De Madrid
C/ Nicolas Cabrera, 1
28049 Madrid / ES
 [2020/20]
Representative(s)Pons
Glorieta Rubén Darío 4
28010 Madrid / ES
[N/P]
Former [2020/20]Pons
Glorieta Ruben Dario 4
28010 Madrid / ES
Application number, filing date18382799.712.11.2018
[2020/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3650466
Date:13.05.2020
Language:EN
[2020/20]
Search report(s)(Supplementary) European search report - dispatched on:EP15.04.2019
ClassificationIPC:C07K16/00, C12N5/0781, C12N5/0783, A61K39/385, C07K14/77
[2020/20]
CPC:
C07K16/00 (EP); C12N5/0636 (EP,US); A61K39/385 (EP);
A61K39/4611 (EP); A61K39/4612 (EP); A61K39/4622 (EP);
A61K39/4644 (EP); C07K14/77 (EP,US); C12N5/0635 (EP,US);
A61K2239/31 (EP); A61K2239/38 (EP); C07K2317/52 (EP,US);
C07K2317/92 (US); C12N2502/1107 (EP,US); C12N2502/1114 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/52]
Former [2020/20]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:IN-VITRO-HERSTELLUNG HOCHAFFINER MONOKLONALER ANTIKÖRPER[2020/20]
English:IN VITRO PRODUCTION OF HIGH AFFINITY MONOCLONAL ANTIBODIES[2020/20]
French:PRODUCTION IN VITRO D'ANTICORPS MONOCLONAUX À AFFINITÉ ÉLEVÉE[2020/20]
Examination procedure13.11.2020Amendment by applicant (claims and/or description)
13.11.2020Examination requested  [2020/52]
13.11.2020Date on which the examining division has become responsible
01.06.2022Application deemed to be withdrawn, date of legal effect  [2022/44]
23.06.2022Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2022/44]
Fees paidRenewal fee
10.11.2020Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.11.202104   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US7943334  (AKIMOTO MASANOBU [JP], et al) [X] 16* claim 2 *;
 [A]EP2574666  (PROTEALMMUN GMBH [DE]) [A] 1-16 * the whole document *;
 [A]EP2711021  (BLINK THERAPEUTICS LTD [GB]) [A] 1-16 * the whole document *;
 [A]WO2015117162  (UNIV SOUTH DAKOTA [US]) [A] 1,2,13 * paragraphs [0003] - [0008] - [0012] , [0023] , [0075]; claim 6 *;
 [A]  - D. PARRA ET AL, "Pivotal Advance: Peritoneal cavity B-1 B cells have phagocytic and microbicidal capacities and present phagocytosed antigen to CD4+ T cells", JOURNAL OF LEUKOCYTE BIOLOGY, US, (20120401), vol. 91, no. 4, doi:10.1189/jlb.0711372, ISSN 0741-5400, pages 525 - 536, XP055574511 [A] 1-16 * abstract * * page 527, paragraph Antigen presentation assays *

DOI:   http://dx.doi.org/10.1189/jlb.0711372
 [A]  - ANA MARTÍNEZ-RIAÑO ET AL, "Antigen phagocytosis by B cells is required for a potent humoral response", EMBO REPORTS, (20180709), vol. 19, no. 9, doi:10.15252/embr.201846016, ISSN 1469-3178, page e46016, XP055574483 [A] 1-16 * abstract * * figure 5 * * page 11, paragraph Materials and Methods - page 13 *

DOI:   http://dx.doi.org/10.15252/embr.201846016
 [AD]  - Takuya Nojima ET AL, "In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo", Nature communications, England, doi:10.1038/ncomms1475, (20110906), page 465, URL: http://www.nature.com/articles/ncomms1475.pdf, (20171017), XP055416496 [AD] 1,2,13 * the whole document *

DOI:   http://dx.doi.org/10.1038/ncomms1475
by applicantUS2010184148
 US2010323401
 WO2011023705
 US2016046907
    - NOJIMA et al., Nat Commun., (20110000), vol. 2, page 465
    - NAIR, S. et al., Curr Protoc Immunol., (20120000), vol. 0 7
    - DELGADO et al., Nat Immunol., (20090000), vol. 10, pages 880 - 888
    - VIGORITO, E. et al., Mol Cell Biol., (20040000), vol. 24, pages 719 - 729
    - SHIH, T.A. et al., Nat Immunol., (20020000), vol. 3, pages 399 - 406
    - BARNDEN, M.J. et al., Immunol Cell Biol., (19980000), vol. 76, pages 34 - 40
    - MOMBAERTS, P. et al., Cell, (19920000), vol. 68, pages 869 - 877
    - MARTINEZ-MARTIN, N. et al., Sci Signal., (20090000), vol. 2, page ra43
    - AIBA, Y., Proc Natl Acad Sci USA., (20100000), vol. 107, pages 12192 - 12197
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.